Emeritus Professor
University of Pennsylvania School of Medicine and
Dorothy Caputo, MA, RN, BC-ADM, CDE, Nurse Planne
In a cohort of patients who started treatment at the National Institutes of Health in 1984, none who achieved sustained response developed
hepatocellular carcinoma, and all had improved measures of liver function
in the long run, reported Christopher Koh, MD, of the National Institute for Diabetes and Digestive and Kidney Diseases, and colleagues.